Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Repligen Corp shares valued at $3,225,927 were sold by Hunt Anthony on Sep 10 ’24. At $145.37 per share, Hunt Anthony sold 22,191 shares. The insider’s holdings dropped to 139,840 shares worth approximately $21.04 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hunt Anthony purchased 22,191 shares, netting a total of over 3,211,481 in proceeds.
Before that, KURIYEL RALF had sold 7,148 shares from its account. In a trade valued at $1,139,016, the Senior VP, R&D traded Repligen Corp shares for $159.35 each. Upon closing the transaction, the insider’s holdings decreased to 7,148 shares, worth approximately $1.85 million.
As published in their initiating research note from Wells Fargo on August 28, 2024, Repligen Corp [RGEN] has been an Overweight and the price target has been revised to $180. Analysts at Deutsche Bank upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late June. As of June 18, 2024, Guggenheim has initiated its “Neutral” rating for RGEN. Earlier on December 04, 2023, The Benchmark Company downgraded its rating. Their new recommendation was “a Hold” for RGEN stock which previously was a “a Buy”.
Analyzing RGEN Stock Performance
During the last five days, there has been a surge of approximately 3.11%. Over the course of the year, Repligen Corp shares have dropped approximately -16.31%. Shares of the company reached a 52-week high of $211.13 on 02/16/24 and a 52-week low of $113.50 on 06/20/24. A 50-day SMA is recorded $141.59, while a 200-day SMA reached $157.90. Nevertheless, trading volume fell to 1.07 million shares from 1.4 million shares the previous day.
Support And Resistance Levels for Repligen Corp (RGEN)
According to the 24-hour chart, there is a support level at 144.84, which, if violated, would cause prices to drop to 139.21. In the upper region, resistance lies at 155.21. The next price resistance is at 159.95. RSI (Relative Strength Index) is 60.54 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 5.38, which suggests the price will increase in the coming days. Percent R is at 19.17%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
